Huang, Nai-Jia
Pishesha, Novalia
Mukherjee, Jean
Zhang, Sicai
Deshycka, Rhogerry
Sudaryo, Valentino
Dong, Min
Shoemaker, Charles B.
Lodish, Harvey F.
Article History
Received: 6 October 2016
Accepted: 8 June 2017
First Online: 4 September 2017
Competing interests
: H.F.L. declares a competing financial interest as a shareholder in Rubius, Inc., a company that seeks to use modified red blood cells for therapeutic use. The remaining authors declare no competing financial interests.